Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

about

Immunomodulatory effects of soluble CD5 on experimental tumor models.Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.

P2860

Q47101681-51683A67-7A6A-49A2-B5AD-FAC1FE7A2813 Q47225780-66B8AA76-C932-44EA-897D-BEF7922907ED

P2860

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

Item

http://www.wikidata.org/entity/Q39306589

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

@en

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

@nl

type

Item

label

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

@en

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

@nl

prefLabel

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

@en

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

@nl

P1476

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1

@en

P2093

Inês Simões

http://www.w3.org/2001/XMLSchema#string

Marcos Vasquez

http://www.w3.org/2001/XMLSchema#string

Pedro Berraondo

http://www.w3.org/2001/XMLSchema#string

P2860

The B-cell surface protein CD72/Lyb-2 is the ligand for CD5

CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1

Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology

The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis

The blockade of immune checkpoints in cancer immunotherapy

Pattern recognition receptors and inflammation

Targeting SR-BI for Cancer Diagnostics, Imaging and Therapy

Functional requirement of tyrosine residue 429 within CD5 cytoplasmic domain for regulation of T cell activation and survival

CD5 is associated with the human B cell antigen receptor complex

A ligand for CD5 is CD5

P304

1108-1118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.201646903

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fernando Aranda

Francisco Lozano

Marta Consuegra-Fernández

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28504304

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

about

P2860

P2860

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921